Follow the Bafna Pharmaceuticals Limited stock price and the full directors' dealings record of the company, a listed equity based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Bafna Pharmaceuticals Limited has published 14 insider filings. Market capitalisation: €1.8bn. The latest transaction was reported on 29 March 2025 (Sale). Among the most active insiders: SRJR LIFESCIENCES LLP. The full history is openly available.
14
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€3m
9 ops.
Sell Volume
10Σ signal
Buys ·€3m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,163 of 26,092 companies
44.5
score / 100
Value
31
Quality
58
FCF yld-2.0%
Earn yld2.3%
EV/EBITDA25.1x
ROE12%
Gross mgn32%
Net mgn7.4%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.